Guardant Health: Fourth Quarter Financial Overview

Guardant Health Reports Fourth Quarter Financial Results

Guardant Health Inc., headquartered in Palo Alto, California, announced a net loss of $128.5 million for the fourth quarter.

The company’s loss amounted to $1 per share during this period. After adjusting for expenses related to stock options and asset impairments, the loss was 50 cents per share.

These figures did not meet analyst expectations, as a consensus of six analysts polled by Zacks Investment Research had anticipated a smaller loss of 42 cents per share.

During the quarter, Guardant Health, which specializes in cancer diagnostic services, generated $281.3 million in revenue.

For the full year, the company reported a total loss of $416.3 million, translating to $3.32 per share, with annual revenue reaching $982 million.

Looking ahead, Guardant Health projects its revenue for the upcoming year to fall between $1.25 billion and $1.28 billion.